Emergence of Desalkylgidazepam: A Novel Benzodiazepine in Canada
This short report provides quick statistics on Desalkylgidazepam, the most identified new psychoactive substance in Canada in 2022 based on samples submitted to the Drug Analysis Service by law enforcement agencies and public health partners.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2026-06-10
Data overview
- Formats
- File languages
- English, French